Our results indicate that inhibition of FoxQ1 expression significantly suppresses the tumorigenicity of human glioblastoma cells, whereas rescue the NRXN3 expression can recover the ability of tumorigenicity. This evidence concerns the gene FOXQ1 and glioblastoma.